To hear about similar clinical trials, please enter your email below
Trial Title:
A Research Registry on Aggressive PitNETs
NCT ID:
NCT05974696
Condition:
Endocrine Tumor
Conditions: Official terms:
Endocrine Gland Neoplasms
Conditions: Keywords:
Endocrine Tumor
Reference centre
rare diseases
transcriptoms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
To allow the identification of markers, it is necessary to extend research networks more
widely to collect and properly explore aggressive pituitary tumours. The
multidisciplinary consultation meeting (RCP), organised by the reference centre for rare
diseases of the pituitary gland, dedicated to aggressive pituitary tumours and carcinomas
(HYPOcare), which is unique in France and brings together national experts, currently
makes it possible to orientate the management of patients with an aggressive pituitary
tumour. With more than 80 patient files discussed since its inception, the patient cohort
via the HYPOcare RCP is one of the largest both nationally and internationally. At
present, this data source is only dedicated to the clinical management of the files
without the possibility of carrying out research work
Criteria for eligibility:
Study pop:
Adult subjects with pituitary tumours whose file is presented to the national HYPOcare
RCP. There is only one group.
Sampling method:
Probability Sample
Criteria:
- Inclusion Criteria :
- Patients with a diagnosis of pituitary tumour
- Patients whose file has been presented to the national HYPOcare RCP
- Exclusion Criteria :
- Patients objecting to participating in this research
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Hospices Civils de Lyon - Groupement Hospitalier Est
Address:
City:
Lyon
Zip:
69003
Country:
France
Status:
Recruiting
Contact:
Last name:
Gérald RAVEROT, PhD - MD
Phone:
4 72 11 93 25
Phone ext:
+33
Email:
gerald.raverot@chu-lyon.fr
Contact backup:
Last name:
Laurent VILLENEUVE
Phone:
4 78 86 45 36
Phone ext:
+33
Email:
laurent.villeneuve@chu-lyon.fr
Investigator:
Last name:
Gérald RAVEROT, PhD - MD
Email:
Principal Investigator
Start date:
June 15, 2023
Completion date:
June 15, 2029
Lead sponsor:
Agency:
Hospices Civils de Lyon
Agency class:
Other
Source:
Hospices Civils de Lyon
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05974696